T1	Disorder 26 40	encephalopathy
N1 	Reference T1 UMLS:C0085584	encephalopathy
T2	Disorder 61 76	trypanosomiasis
N2 	Reference T2 UMLS:C0041227	trypanosomiasis
T3	Disorder 215 238	african trypanosomiasis
N3 	Reference T3 UMLS:C0041228	african trypanosomiasis
T4	Pharmacological_substance 402 413	melarsoprol
N1000 	Reference T4 MeSH:D008549	melarsoprol
T5	Disorder 564 597	arsenical reactive encephalopathy
T6	Disorder 620 637	sleeping sickness
N4 	Reference T6 UMLS:C0041228	sleeping sickness
T8	Pharmacological_substance 728 739	melarsoprol
N1001 	Reference T8 MeSH:D008549	melarsoprol
T10	Pharmacological_substance 1055 1068	thiabendazole
N1002 	Reference T10 MeSH:D013827	thiabendazole
T11	Disorder 1078 1094	strongyloidiasis
N5 	Reference T11 UMLS:C0038463	strongyloidiasis
T12	Pharmacological_substance 1106 1117	melarsoprol
N1003 	Reference T12 MeSH:D008549	melarsoprol
T13	Pharmacological_substance 1332 1347	anti-helminthic
N1004 	Reference T13 MeSH:D000947	anti-helminthic
N1005 	Reference T13 MeSH:D000947	anti-helminthic
T14	Pharmacological_substance 1444 1455	melarsoprol
N1006 	Reference T14 MeSH:D008549	melarsoprol
T15	Disorder 599 602	ARE
N6 	Reference T15 UMLS:C0004763	ARE
T16	Disorder 1030 1033	ARE
N7 	Reference T16 UMLS:C0004763	ARE
T17	Disorder 1268 1271	ARE
N8 	Reference T17 UMLS:C0004763	ARE
T22	Disorder 675 678	ARE
N9 	Reference T22 UMLS:C0004763	ARE
T23	Speculation_cue 1022 1026	risk
T7	Combination 1095 1101	during
